Sponsored Links
| New First-in-class Treatment, Trobalt(R), Launched Today As An Adjunct Therapy In Patients With Difficult To Control Epilepsy |
 |
 |
 |
| Medical News - Epilepsy | |||
|
GlaxoSmithKline has today launched Trobalt® (retigabine), the first in a new class of anti-epileptic drug (AED), for the adjunct treatment of adults with partial-onset seizures, and demonstrated significant effects in a treatment resistant patient population... Read more: Epilepsy News From Medical News Today
|